Interleukin-7 protects CD8+ T cells from adenosine-mediated immunosuppression
buir.contributor.author | Koyaş, Altay | |
buir.contributor.author | Tüçer, Suat | |
buir.contributor.author | Kayhan, Merve | |
buir.contributor.author | Savaş, Ali Can | |
buir.contributor.author | Akdemir, İmran | |
buir.contributor.author | Çekiç, Çağlar | |
buir.contributor.orcid | Koyaş, Altay|0000-0002-5436-6038 | |
buir.contributor.orcid | Tüçer, Suat|0000-0002-6629-0093 | |
buir.contributor.orcid | Kayhan, Merve|0000-0001-6089-5086 | |
buir.contributor.orcid | Savaş, Ali Can|0000-0002-2630-9765 | |
buir.contributor.orcid | Akdemir, İmran|0000-0002-8540-6741 | |
buir.contributor.orcid | Çekiç, Çağlar|0000-0001-8081-508X | |
dc.citation.epage | 8 | en_US |
dc.citation.issueNumber | 674 | en_US |
dc.citation.spage | 1 | en_US |
dc.citation.volumeNumber | 14 | en_US |
dc.contributor.author | Koyaş, Altay | |
dc.contributor.author | Tüçer, Suat | |
dc.contributor.author | Kayhan, Merve | |
dc.contributor.author | Savaş, Ali Can | |
dc.contributor.author | Akdemir, İmran | |
dc.contributor.author | Çekiç, Çağlar | |
dc.date.accessioned | 2022-01-27T12:12:11Z | |
dc.date.available | 2022-01-27T12:12:11Z | |
dc.date.issued | 2021-03-16 | |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | The nucleoside adenosine accumulates extracellularly in solid tumors and inhibits CD8+ T cells by activating adenosine receptors. The cytokine interleukin-7 (IL-7), which is produced by various tissues and tumors, promotes the survival and maintenance of T cells. Adenosine and IL-7 signaling are being clinically targeted separately or in combination with other therapies for solid tumor indications. Here, we found that IL-7 signaling promoted the accumulation of tumor-associated CD8+ T cells, in part, by preventing adenosine-mediated immunosuppression. Inhibition of the transcription factor FoxO1 downstream of IL-7 receptor signaling was important for protecting CD8+ T cells from suppression by adenosine. These findings have implications for the development of new approaches for cancer immunotherapies that target the adenosine pathway. | en_US |
dc.identifier.doi | 10.1126/scisignal.abb1269 | en_US |
dc.identifier.eissn | 1937-9145 | |
dc.identifier.issn | 1945-0877 | |
dc.identifier.uri | http://hdl.handle.net/11693/76840 | |
dc.language.iso | English | en_US |
dc.publisher | American Association for the Advancement of Science (AAAS) | en_US |
dc.relation.isversionof | https://dx.doi.org/10.1126/scisignal.abb1269 | en_US |
dc.source.title | Science Signaling | en_US |
dc.title | Interleukin-7 protects CD8+ T cells from adenosine-mediated immunosuppression | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Interleukin_7_protects_CD8+T_cells_from_adenosine_mediated_immunosuppression.pdf
- Size:
- 1.5 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.69 KB
- Format:
- Item-specific license agreed upon to submission
- Description: